|
gptkbp:instanceOf
|
gptkb:government_agency
|
|
gptkbp:administeredBy
|
gptkb:Office_of_the_Assistant_Secretary_for_Preparedness_and_Response
gptkb:U.S._Department_of_Health_and_Human_Services
|
|
gptkbp:budget
|
$5.6 billion (initial 10-year period)
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:dateEnacted
|
2004
|
|
gptkbp:enables
|
Emergency use authorization of unapproved medical products
|
|
gptkbp:establishedBy
|
gptkb:Project_BioShield_Act_of_2004
|
|
gptkbp:focus
|
gptkb:Bioterrorism
Chemical threats
Nuclear threats
Radiological threats
|
|
gptkbp:fundedBy
|
gptkb:U.S._federal_government
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Project BioShield
|
|
gptkbp:provides
|
Funding for diagnostics
Funding for therapeutics
Funding for vaccines
|
|
gptkbp:purpose
|
Accelerate development and procurement of medical countermeasures against bioterrorism
|
|
gptkbp:relatedTo
|
gptkb:Biomedical_Advanced_Research_and_Development_Authority
gptkb:Strategic_National_Stockpile
gptkb:Public_Health_Emergency_Medical_Countermeasures_Enterprise
|
|
gptkbp:website
|
https://www.phe.gov/about/barda/Pages/projectbioshield.aspx
|
|
gptkbp:bfsParent
|
gptkb:Biomedical_Advanced_Research_and_Development_Authority
gptkb:BARDA
|
|
gptkbp:bfsLayer
|
6
|